We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$506M
AUM Growth
-$3.29M
Cap. Flow
-$18.8M
Cap. Flow %
-3.7%
Top 10 Hldgs %
32.15%
Holding
204
New
52
Increased
17
Reduced
40
Closed
57

Top Buys

Rank Stock Value
1
HSP
HOSPIRA INC
HSP
+$11.7M
2
ADM icon
Archer Daniels Midland
ADM
+$11.5M
3
EQR icon
Equity Residential
EQR
+$11M
4
MMM icon
3M
MMM
+$10.9M
5
BP icon
BP
BP
+$10.9M

Sector Composition

Rank Sector Weight
1 Healthcare 19.03%
2 Technology 13.94%
3 Industrials 12.88%
4 Financials 11.74%
5 Energy 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
1
Gilead Sciences
GILD
$161B
$20.3M 4.01%
244,573
-22,361
-8% -$1.74M
SNDK
2
DELISTED
SANDISK CORP
SNDK
$18.1M 3.58%
173,594
-13,343
-7% -$1.21M
HAL icon
3
Halliburton
HAL
$27.9B
$17.4M 3.44%
244,987
-15,417
-6% -$988K
MCO icon
4
Moody's
MCO
$82.4B
$17.3M 3.42%
197,712
-11,897
-6% -$980K
PARA
5
DELISTED
Paramount Global Class B
PARA
$17.2M 3.39%
276,005
-13,051
-5% -$777K
ALV icon
6
Autoliv
ALV
$8.6B
$14.7M 2.91%
191,516
-10,867
-5% -$812K
HUM icon
7
Humana
HUM
$46.7B
$14.7M 2.9%
115,084
-5,516
-5% -$653K
AIG icon
8
American International
AIG
$41.9B
$14.7M 2.9%
269,176
-13,563
-5% -$718K
CTAS icon
9
Cintas
CTAS
$82.4B
$14.3M 2.83%
902,556
-36,908
-4% -$558K
RTN
10
DELISTED
Raytheon Company
RTN
$14M 2.77%
152,032
-10,533
-6% -$1.02M
MA icon
11
Mastercard
MA
$477B
$14M 2.77%
190,765
-9,620
-5% -$715K
ASH icon
12
Ashland
ASH
$3.04B
$14M 2.76%
262,789
-12,589
-5% -$628K
CVS icon
13
CVS Health
CVS
$137B
$13.7M 2.7%
181,445
-11,864
-6% -$897K
AMGN icon
14
Amgen
AMGN
$203B
$13.3M 2.62%
112,171
-5,312
-5% -$615K
IRF
15
DELISTED
INTL RECTIFIER CORP
IRF
$13.1M 2.59%
469,647
-24,105
-5% -$646K
HSP
16
DELISTED
HOSPIRA INC
HSP
$12.7M 2.5%
+246,739
New +$11.7M
CVG
17
DELISTED
Convergys
CVG
$12.4M 2.45%
578,355
-29,323
-5% -$636K
INVX
18
Innovex International
INVX
$1.87B
$12.4M 2.45%
113,323
-3,932
-3% -$423K
RTX icon
19
RTX Corp
RTX
$287B
$12.2M 2.41%
167,970
-13,387
-7% -$986K
BAC icon
20
Bank of America
BAC
$435B
$12M 2.38%
783,413
-18,563
-2% -$288K
GNTX icon
21
Gentex
GNTX
$4.88B
$11.7M 2.32%
806,152
-39,570
-5% -$578K
OTEX icon
22
Open Text
OTEX
$5.43B
$11.6M 2.29%
483,550
-13,314
-3% -$316K
BDC icon
23
Belden
BDC
$4B
$11.6M 2.28%
147,947
-6,177
-4% -$453K
ADM icon
24
Archer Daniels Midland
ADM
$41.4B
$11.5M 2.27%
+260,749
New +$11.5M
VMW
25
DELISTED
VMware, Inc
VMW
$11.4M 2.25%
117,796
-5,365
-4% -$522K

Similar funds

Contravisory Investment Management's Q2 2014 Portfolio in Review

As of Q2 2014, Contravisory Investment Management held 204 positions worth $506M, down 0.64% from $509M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Contravisory Investment Management withdrew a net $18.8M in Q2 2014, closing 57 positions and reducing 40 holdings. Its most notable exit was Kansas City Southern, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

Against the trend, Contravisory Investment Management opened a new position in HOSPIRA INC worth $12.7M.

  • Contravisory Investment Management's largest Q2 2014 buy was HOSPIRA INC: 246,739 shares worth $12.7M.
  • Contravisory Investment Management added most to ExxonMobil in Q2 2014, an estimated $10.8M increase.
  • Contravisory Investment Management's biggest Q2 2014 reduction was Citigroup, cutting an estimated $9.99M.
  • Contravisory Investment Management fully exited Kansas City Southern in Q2 2014, selling an estimated $13.8M.
  • Contravisory Investment Management's ten largest holdings make up 32% of its $506M portfolio in Q2 2014.
  • Contravisory Investment Management opened 52 new positions and closed 57 in Q2 2014.
  • Contravisory Investment Management's portfolio value fell 0.64% quarter-over-quarter to $506M.

Based on Contravisory Investment Management's 13F filing for Q2 2014, filed 17 Jul 2014.